This week in Singapore, NTI joins experts for the Seventh International Meeting on Synthetic Biology (SB 7.0). SB 7.0 is a global gathering of leading institutions focused on realizing societal benefits from synthetic biology and discussing responsible practices. Beth Cameron, NTI’s Senior Director for Global Biological Policy and Programs, was invited to participate in a security-centered dialogue during this year’s event that will focus on assessing and reducing risks posed by emerging technologies and their applications.
Cameron will urge gathered innovators to consider new and global strategies for mitigating the risk of intentional misuse or accidental release associated with emerging technologies in genome editing and synthetic biology, while maximizing the potential for positive societal benefits. Cameron also will discuss NTI’s perspectives on biosecurity, threat reduction, and global health security with selected emerging leaders organized by the Johns Hopkins Center for Health Security with funding from the Open Philanthropy Project part of a new track focused on biosecurity and synthetic biology during SB 7.0 in coordination with the BioBricks Foundation, SynBioBeta, & the National University of Singapore.
Read more about NTI’s biosecurity program here.